nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CA9—kidney cancer	0.324	0.526	CbGaD
Brinzolamide—CA2—kidney cancer	0.291	0.473	CbGaD
Brinzolamide—CYP3A4—Everolimus—kidney cancer	0.0236	0.293	CbGbCtD
Brinzolamide—CYP3A4—Temsirolimus—kidney cancer	0.0159	0.198	CbGbCtD
Brinzolamide—CYP3A4—Pazopanib—kidney cancer	0.00837	0.104	CbGbCtD
Brinzolamide—CA2—collecting duct of renal tubule—kidney cancer	0.00699	0.258	CbGeAlD
Brinzolamide—CYP3A4—Erlotinib—kidney cancer	0.00597	0.0741	CbGbCtD
Brinzolamide—CYP3A4—Paclitaxel—kidney cancer	0.00546	0.0678	CbGbCtD
Brinzolamide—CYP3A4—Sorafenib—kidney cancer	0.00485	0.0603	CbGbCtD
Brinzolamide—CYP3A4—Vinblastine—kidney cancer	0.00479	0.0595	CbGbCtD
Brinzolamide—CYP3A4—Vincristine—kidney cancer	0.00471	0.0585	CbGbCtD
Brinzolamide—CYP3A4—Sunitinib—kidney cancer	0.00393	0.0488	CbGbCtD
Brinzolamide—CYP3A4—Doxorubicin—kidney cancer	0.00294	0.0366	CbGbCtD
Brinzolamide—Dorzolamide—CA9—kidney cancer	0.00289	0.526	CrCbGaD
Brinzolamide—Dorzolamide—CA2—kidney cancer	0.00259	0.473	CrCbGaD
Brinzolamide—CA7—renal system—kidney cancer	0.00183	0.0677	CbGeAlD
Brinzolamide—CA7—kidney—kidney cancer	0.00177	0.0654	CbGeAlD
Brinzolamide—CYP3A4—urine—kidney cancer	0.00161	0.0595	CbGeAlD
Brinzolamide—CA14—cardiac atrium—kidney cancer	0.00137	0.0505	CbGeAlD
Brinzolamide—CA12—renal system—kidney cancer	0.00119	0.044	CbGeAlD
Brinzolamide—CA12—kidney—kidney cancer	0.00115	0.0425	CbGeAlD
Brinzolamide—CA5B—gonad—kidney cancer	0.000957	0.0354	CbGeAlD
Brinzolamide—CA5B—cardiac atrium—kidney cancer	0.000956	0.0353	CbGeAlD
Brinzolamide—CA1—renal system—kidney cancer	0.000943	0.0348	CbGeAlD
Brinzolamide—CA1—kidney—kidney cancer	0.000911	0.0337	CbGeAlD
Brinzolamide—CA4—nephron tubule—kidney cancer	0.000811	0.0299	CbGeAlD
Brinzolamide—CA4—renal system—kidney cancer	0.000737	0.0272	CbGeAlD
Brinzolamide—CA4—kidney—kidney cancer	0.000712	0.0263	CbGeAlD
Brinzolamide—CA4—cortex of kidney—kidney cancer	0.000694	0.0256	CbGeAlD
Brinzolamide—CA2—nephron tubule—kidney cancer	0.000672	0.0248	CbGeAlD
Brinzolamide—CA4—cardiac atrium—kidney cancer	0.00066	0.0244	CbGeAlD
Brinzolamide—CA2—renal system—kidney cancer	0.000611	0.0226	CbGeAlD
Brinzolamide—CA2—kidney—kidney cancer	0.000591	0.0218	CbGeAlD
Brinzolamide—CA2—cortex of kidney—kidney cancer	0.000575	0.0213	CbGeAlD
Brinzolamide—CA2—cardiac atrium—kidney cancer	0.000547	0.0202	CbGeAlD
Brinzolamide—CYP3A4—renal system—kidney cancer	0.000394	0.0146	CbGeAlD
Brinzolamide—CYP3A4—kidney—kidney cancer	0.000381	0.0141	CbGeAlD
Brinzolamide—Connective tissue disorder—Capecitabine—kidney cancer	0.000109	0.000651	CcSEcCtD
Brinzolamide—Vomiting—Everolimus—kidney cancer	0.000108	0.00065	CcSEcCtD
Brinzolamide—Urethral disorder—Capecitabine—kidney cancer	0.000108	0.00065	CcSEcCtD
Brinzolamide—Paraesthesia—Vincristine—kidney cancer	0.000108	0.000649	CcSEcCtD
Brinzolamide—Agitation—Paclitaxel—kidney cancer	0.000108	0.000646	CcSEcCtD
Brinzolamide—Rash—Everolimus—kidney cancer	0.000108	0.000645	CcSEcCtD
Brinzolamide—Dermatitis—Everolimus—kidney cancer	0.000107	0.000644	CcSEcCtD
Brinzolamide—Headache—Vinblastine—kidney cancer	0.000107	0.000643	CcSEcCtD
Brinzolamide—Headache—Everolimus—kidney cancer	0.000107	0.000641	CcSEcCtD
Brinzolamide—Hypotension—Gemcitabine—kidney cancer	0.000107	0.00064	CcSEcCtD
Brinzolamide—Visual impairment—Capecitabine—kidney cancer	0.000107	0.000639	CcSEcCtD
Brinzolamide—Asthenia—Sorafenib—kidney cancer	0.000106	0.000637	CcSEcCtD
Brinzolamide—Malaise—Paclitaxel—kidney cancer	0.000106	0.000634	CcSEcCtD
Brinzolamide—Vertigo—Paclitaxel—kidney cancer	0.000105	0.000632	CcSEcCtD
Brinzolamide—Hypersensitivity—Sunitinib—kidney cancer	0.000105	0.000629	CcSEcCtD
Brinzolamide—Decreased appetite—Vincristine—kidney cancer	0.000105	0.000628	CcSEcCtD
Brinzolamide—Pruritus—Sorafenib—kidney cancer	0.000105	0.000628	CcSEcCtD
Brinzolamide—Vomiting—Erlotinib—kidney cancer	0.000105	0.000627	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000104	0.000624	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Vincristine—kidney cancer	0.000104	0.000624	CcSEcCtD
Brinzolamide—Fatigue—Vincristine—kidney cancer	0.000104	0.000623	CcSEcCtD
Brinzolamide—Rash—Erlotinib—kidney cancer	0.000104	0.000622	CcSEcCtD
Brinzolamide—Dermatitis—Erlotinib—kidney cancer	0.000104	0.000621	CcSEcCtD
Brinzolamide—Palpitations—Paclitaxel—kidney cancer	0.000104	0.000621	CcSEcCtD
Brinzolamide—Insomnia—Gemcitabine—kidney cancer	0.000103	0.00062	CcSEcCtD
Brinzolamide—Eye disorder—Capecitabine—kidney cancer	0.000103	0.000619	CcSEcCtD
Brinzolamide—Headache—Erlotinib—kidney cancer	0.000103	0.000618	CcSEcCtD
Brinzolamide—Tinnitus—Capecitabine—kidney cancer	0.000103	0.000618	CcSEcCtD
Brinzolamide—Pain—Vincristine—kidney cancer	0.000103	0.000618	CcSEcCtD
Brinzolamide—Pain in extremity—Doxorubicin—kidney cancer	0.000103	0.000618	CcSEcCtD
Brinzolamide—Diplopia—Doxorubicin—kidney cancer	0.000103	0.000618	CcSEcCtD
Brinzolamide—Paraesthesia—Gemcitabine—kidney cancer	0.000103	0.000615	CcSEcCtD
Brinzolamide—Cardiac disorder—Capecitabine—kidney cancer	0.000103	0.000615	CcSEcCtD
Brinzolamide—Cough—Paclitaxel—kidney cancer	0.000102	0.000613	CcSEcCtD
Brinzolamide—Asthenia—Sunitinib—kidney cancer	0.000102	0.000613	CcSEcCtD
Brinzolamide—Dyspnoea—Gemcitabine—kidney cancer	0.000102	0.000611	CcSEcCtD
Brinzolamide—Nausea—Vinblastine—kidney cancer	0.000102	0.00061	CcSEcCtD
Brinzolamide—Somnolence—Gemcitabine—kidney cancer	0.000102	0.000609	CcSEcCtD
Brinzolamide—Nausea—Everolimus—kidney cancer	0.000101	0.000607	CcSEcCtD
Brinzolamide—Diarrhoea—Sorafenib—kidney cancer	0.000101	0.000607	CcSEcCtD
Brinzolamide—Hypertension—Paclitaxel—kidney cancer	0.000101	0.000607	CcSEcCtD
Brinzolamide—Pruritus—Sunitinib—kidney cancer	0.000101	0.000604	CcSEcCtD
Brinzolamide—Angiopathy—Capecitabine—kidney cancer	0.0001	0.000601	CcSEcCtD
Brinzolamide—Immune system disorder—Capecitabine—kidney cancer	9.99e-05	0.000599	CcSEcCtD
Brinzolamide—Arthralgia—Paclitaxel—kidney cancer	9.98e-05	0.000598	CcSEcCtD
Brinzolamide—Myalgia—Paclitaxel—kidney cancer	9.98e-05	0.000598	CcSEcCtD
Brinzolamide—Chest pain—Paclitaxel—kidney cancer	9.98e-05	0.000598	CcSEcCtD
Brinzolamide—Mediastinal disorder—Capecitabine—kidney cancer	9.96e-05	0.000597	CcSEcCtD
Brinzolamide—Decreased appetite—Gemcitabine—kidney cancer	9.94e-05	0.000596	CcSEcCtD
Brinzolamide—Hypersensitivity—Dactinomycin—kidney cancer	9.94e-05	0.000596	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	9.92e-05	0.000594	CcSEcCtD
Brinzolamide—Arrhythmia—Capecitabine—kidney cancer	9.88e-05	0.000592	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Gemcitabine—kidney cancer	9.87e-05	0.000592	CcSEcCtD
Brinzolamide—Discomfort—Paclitaxel—kidney cancer	9.87e-05	0.000591	CcSEcCtD
Brinzolamide—Fatigue—Gemcitabine—kidney cancer	9.86e-05	0.000591	CcSEcCtD
Brinzolamide—Dizziness—Sorafenib—kidney cancer	9.79e-05	0.000587	CcSEcCtD
Brinzolamide—Pain—Gemcitabine—kidney cancer	9.78e-05	0.000586	CcSEcCtD
Brinzolamide—Nausea—Erlotinib—kidney cancer	9.78e-05	0.000586	CcSEcCtD
Brinzolamide—Alopecia—Capecitabine—kidney cancer	9.77e-05	0.000586	CcSEcCtD
Brinzolamide—Dry mouth—Paclitaxel—kidney cancer	9.77e-05	0.000585	CcSEcCtD
Brinzolamide—Diarrhoea—Sunitinib—kidney cancer	9.75e-05	0.000584	CcSEcCtD
Brinzolamide—Mental disorder—Capecitabine—kidney cancer	9.69e-05	0.000581	CcSEcCtD
Brinzolamide—Asthenia—Dactinomycin—kidney cancer	9.68e-05	0.00058	CcSEcCtD
Brinzolamide—Erythema—Capecitabine—kidney cancer	9.62e-05	0.000577	CcSEcCtD
Brinzolamide—Malnutrition—Capecitabine—kidney cancer	9.62e-05	0.000577	CcSEcCtD
Brinzolamide—Liver function test abnormal—Doxorubicin—kidney cancer	9.51e-05	0.00057	CcSEcCtD
Brinzolamide—Infection—Paclitaxel—kidney cancer	9.51e-05	0.00057	CcSEcCtD
Brinzolamide—Flatulence—Capecitabine—kidney cancer	9.48e-05	0.000568	CcSEcCtD
Brinzolamide—Dysgeusia—Capecitabine—kidney cancer	9.42e-05	0.000565	CcSEcCtD
Brinzolamide—Dizziness—Sunitinib—kidney cancer	9.42e-05	0.000565	CcSEcCtD
Brinzolamide—Feeling abnormal—Gemcitabine—kidney cancer	9.42e-05	0.000565	CcSEcCtD
Brinzolamide—Vomiting—Sorafenib—kidney cancer	9.41e-05	0.000564	CcSEcCtD
Brinzolamide—Abdominal pain upper—Doxorubicin—kidney cancer	9.41e-05	0.000564	CcSEcCtD
Brinzolamide—Nervous system disorder—Paclitaxel—kidney cancer	9.39e-05	0.000563	CcSEcCtD
Brinzolamide—Tachycardia—Paclitaxel—kidney cancer	9.34e-05	0.00056	CcSEcCtD
Brinzolamide—Rash—Sorafenib—kidney cancer	9.34e-05	0.00056	CcSEcCtD
Brinzolamide—Dermatitis—Sorafenib—kidney cancer	9.33e-05	0.000559	CcSEcCtD
Brinzolamide—Back pain—Capecitabine—kidney cancer	9.31e-05	0.000558	CcSEcCtD
Brinzolamide—Breast disorder—Doxorubicin—kidney cancer	9.31e-05	0.000558	CcSEcCtD
Brinzolamide—Skin disorder—Paclitaxel—kidney cancer	9.3e-05	0.000557	CcSEcCtD
Brinzolamide—Headache—Sorafenib—kidney cancer	9.28e-05	0.000556	CcSEcCtD
Brinzolamide—Muscle spasms—Capecitabine—kidney cancer	9.25e-05	0.000555	CcSEcCtD
Brinzolamide—Diarrhoea—Dactinomycin—kidney cancer	9.23e-05	0.000553	CcSEcCtD
Brinzolamide—Nasopharyngitis—Doxorubicin—kidney cancer	9.21e-05	0.000552	CcSEcCtD
Brinzolamide—Vision blurred—Capecitabine—kidney cancer	9.07e-05	0.000544	CcSEcCtD
Brinzolamide—Vomiting—Sunitinib—kidney cancer	9.06e-05	0.000543	CcSEcCtD
Brinzolamide—Tremor—Capecitabine—kidney cancer	9.02e-05	0.00054	CcSEcCtD
Brinzolamide—Rash—Sunitinib—kidney cancer	8.98e-05	0.000538	CcSEcCtD
Brinzolamide—Dermatitis—Sunitinib—kidney cancer	8.98e-05	0.000538	CcSEcCtD
Brinzolamide—Hypotension—Paclitaxel—kidney cancer	8.94e-05	0.000536	CcSEcCtD
Brinzolamide—Ill-defined disorder—Capecitabine—kidney cancer	8.93e-05	0.000535	CcSEcCtD
Brinzolamide—Headache—Sunitinib—kidney cancer	8.93e-05	0.000535	CcSEcCtD
Brinzolamide—Asthma—Doxorubicin—kidney cancer	8.9e-05	0.000534	CcSEcCtD
Brinzolamide—Hypersensitivity—Vincristine—kidney cancer	8.88e-05	0.000532	CcSEcCtD
Brinzolamide—Nausea—Sorafenib—kidney cancer	8.8e-05	0.000527	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	8.72e-05	0.000523	CcSEcCtD
Brinzolamide—Malaise—Capecitabine—kidney cancer	8.68e-05	0.00052	CcSEcCtD
Brinzolamide—Angina pectoris—Doxorubicin—kidney cancer	8.67e-05	0.00052	CcSEcCtD
Brinzolamide—Insomnia—Paclitaxel—kidney cancer	8.66e-05	0.000519	CcSEcCtD
Brinzolamide—Vertigo—Capecitabine—kidney cancer	8.65e-05	0.000518	CcSEcCtD
Brinzolamide—Asthenia—Vincristine—kidney cancer	8.65e-05	0.000518	CcSEcCtD
Brinzolamide—Paraesthesia—Paclitaxel—kidney cancer	8.59e-05	0.000515	CcSEcCtD
Brinzolamide—Vomiting—Dactinomycin—kidney cancer	8.58e-05	0.000514	CcSEcCtD
Brinzolamide—Bronchitis—Doxorubicin—kidney cancer	8.56e-05	0.000513	CcSEcCtD
Brinzolamide—Dyspnoea—Paclitaxel—kidney cancer	8.53e-05	0.000512	CcSEcCtD
Brinzolamide—Somnolence—Paclitaxel—kidney cancer	8.51e-05	0.00051	CcSEcCtD
Brinzolamide—Palpitations—Capecitabine—kidney cancer	8.51e-05	0.00051	CcSEcCtD
Brinzolamide—Rash—Dactinomycin—kidney cancer	8.5e-05	0.00051	CcSEcCtD
Brinzolamide—Nausea—Sunitinib—kidney cancer	8.46e-05	0.000507	CcSEcCtD
Brinzolamide—Dyspepsia—Paclitaxel—kidney cancer	8.43e-05	0.000505	CcSEcCtD
Brinzolamide—Cough—Capecitabine—kidney cancer	8.4e-05	0.000503	CcSEcCtD
Brinzolamide—Decreased appetite—Paclitaxel—kidney cancer	8.32e-05	0.000499	CcSEcCtD
Brinzolamide—Hypertension—Capecitabine—kidney cancer	8.31e-05	0.000498	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Paclitaxel—kidney cancer	8.26e-05	0.000495	CcSEcCtD
Brinzolamide—Fatigue—Paclitaxel—kidney cancer	8.25e-05	0.000495	CcSEcCtD
Brinzolamide—Diarrhoea—Vincristine—kidney cancer	8.25e-05	0.000494	CcSEcCtD
Brinzolamide—Pollakiuria—Doxorubicin—kidney cancer	8.23e-05	0.000493	CcSEcCtD
Brinzolamide—Asthenia—Gemcitabine—kidney cancer	8.2e-05	0.000492	CcSEcCtD
Brinzolamide—Arthralgia—Capecitabine—kidney cancer	8.19e-05	0.000491	CcSEcCtD
Brinzolamide—Chest pain—Capecitabine—kidney cancer	8.19e-05	0.000491	CcSEcCtD
Brinzolamide—Myalgia—Capecitabine—kidney cancer	8.19e-05	0.000491	CcSEcCtD
Brinzolamide—Pain—Paclitaxel—kidney cancer	8.19e-05	0.000491	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	8.14e-05	0.000488	CcSEcCtD
Brinzolamide—Discomfort—Capecitabine—kidney cancer	8.1e-05	0.000485	CcSEcCtD
Brinzolamide—Pruritus—Gemcitabine—kidney cancer	8.09e-05	0.000485	CcSEcCtD
Brinzolamide—Dry mouth—Capecitabine—kidney cancer	8.01e-05	0.00048	CcSEcCtD
Brinzolamide—Nausea—Dactinomycin—kidney cancer	8.01e-05	0.00048	CcSEcCtD
Brinzolamide—Dizziness—Vincristine—kidney cancer	7.97e-05	0.000478	CcSEcCtD
Brinzolamide—Infestation NOS—Doxorubicin—kidney cancer	7.94e-05	0.000476	CcSEcCtD
Brinzolamide—Infestation—Doxorubicin—kidney cancer	7.94e-05	0.000476	CcSEcCtD
Brinzolamide—Feeling abnormal—Paclitaxel—kidney cancer	7.89e-05	0.000473	CcSEcCtD
Brinzolamide—Diarrhoea—Gemcitabine—kidney cancer	7.82e-05	0.000469	CcSEcCtD
Brinzolamide—Infection—Capecitabine—kidney cancer	7.8e-05	0.000468	CcSEcCtD
Brinzolamide—Conjunctivitis—Doxorubicin—kidney cancer	7.72e-05	0.000463	CcSEcCtD
Brinzolamide—Nervous system disorder—Capecitabine—kidney cancer	7.7e-05	0.000462	CcSEcCtD
Brinzolamide—Tachycardia—Capecitabine—kidney cancer	7.67e-05	0.00046	CcSEcCtD
Brinzolamide—Vomiting—Vincristine—kidney cancer	7.66e-05	0.000459	CcSEcCtD
Brinzolamide—Skin disorder—Capecitabine—kidney cancer	7.63e-05	0.000457	CcSEcCtD
Brinzolamide—Urticaria—Paclitaxel—kidney cancer	7.6e-05	0.000456	CcSEcCtD
Brinzolamide—Rash—Vincristine—kidney cancer	7.6e-05	0.000455	CcSEcCtD
Brinzolamide—Dermatitis—Vincristine—kidney cancer	7.59e-05	0.000455	CcSEcCtD
Brinzolamide—Headache—Vincristine—kidney cancer	7.55e-05	0.000453	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Doxorubicin—kidney cancer	7.51e-05	0.00045	CcSEcCtD
Brinzolamide—Epistaxis—Doxorubicin—kidney cancer	7.49e-05	0.000449	CcSEcCtD
Brinzolamide—Sinusitis—Doxorubicin—kidney cancer	7.45e-05	0.000446	CcSEcCtD
Brinzolamide—Hypotension—Capecitabine—kidney cancer	7.34e-05	0.00044	CcSEcCtD
Brinzolamide—Vomiting—Gemcitabine—kidney cancer	7.27e-05	0.000436	CcSEcCtD
Brinzolamide—Bradycardia—Doxorubicin—kidney cancer	7.26e-05	0.000435	CcSEcCtD
Brinzolamide—Rash—Gemcitabine—kidney cancer	7.21e-05	0.000432	CcSEcCtD
Brinzolamide—Dermatitis—Gemcitabine—kidney cancer	7.2e-05	0.000432	CcSEcCtD
Brinzolamide—Headache—Gemcitabine—kidney cancer	7.16e-05	0.000429	CcSEcCtD
Brinzolamide—Nausea—Vincristine—kidney cancer	7.16e-05	0.000429	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Capecitabine—kidney cancer	7.16e-05	0.000429	CcSEcCtD
Brinzolamide—Rhinitis—Doxorubicin—kidney cancer	7.14e-05	0.000428	CcSEcCtD
Brinzolamide—Insomnia—Capecitabine—kidney cancer	7.1e-05	0.000426	CcSEcCtD
Brinzolamide—Hypoaesthesia—Doxorubicin—kidney cancer	7.09e-05	0.000425	CcSEcCtD
Brinzolamide—Pharyngitis—Doxorubicin—kidney cancer	7.07e-05	0.000424	CcSEcCtD
Brinzolamide—Paraesthesia—Capecitabine—kidney cancer	7.05e-05	0.000423	CcSEcCtD
Brinzolamide—Hypersensitivity—Paclitaxel—kidney cancer	7.05e-05	0.000423	CcSEcCtD
Brinzolamide—Urinary tract disorder—Doxorubicin—kidney cancer	7.04e-05	0.000422	CcSEcCtD
Brinzolamide—Oedema peripheral—Doxorubicin—kidney cancer	7.02e-05	0.000421	CcSEcCtD
Brinzolamide—Connective tissue disorder—Doxorubicin—kidney cancer	7e-05	0.00042	CcSEcCtD
Brinzolamide—Dyspnoea—Capecitabine—kidney cancer	7e-05	0.00042	CcSEcCtD
Brinzolamide—Urethral disorder—Doxorubicin—kidney cancer	6.99e-05	0.000419	CcSEcCtD
Brinzolamide—Dyspepsia—Capecitabine—kidney cancer	6.91e-05	0.000414	CcSEcCtD
Brinzolamide—Visual impairment—Doxorubicin—kidney cancer	6.87e-05	0.000412	CcSEcCtD
Brinzolamide—Asthenia—Paclitaxel—kidney cancer	6.87e-05	0.000412	CcSEcCtD
Brinzolamide—Decreased appetite—Capecitabine—kidney cancer	6.83e-05	0.000409	CcSEcCtD
Brinzolamide—Nausea—Gemcitabine—kidney cancer	6.79e-05	0.000407	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Capecitabine—kidney cancer	6.78e-05	0.000406	CcSEcCtD
Brinzolamide—Fatigue—Capecitabine—kidney cancer	6.77e-05	0.000406	CcSEcCtD
Brinzolamide—Pruritus—Paclitaxel—kidney cancer	6.77e-05	0.000406	CcSEcCtD
Brinzolamide—Pain—Capecitabine—kidney cancer	6.72e-05	0.000403	CcSEcCtD
Brinzolamide—Eye disorder—Doxorubicin—kidney cancer	6.66e-05	0.000399	CcSEcCtD
Brinzolamide—Tinnitus—Doxorubicin—kidney cancer	6.64e-05	0.000398	CcSEcCtD
Brinzolamide—Cardiac disorder—Doxorubicin—kidney cancer	6.61e-05	0.000396	CcSEcCtD
Brinzolamide—Diarrhoea—Paclitaxel—kidney cancer	6.55e-05	0.000393	CcSEcCtD
Brinzolamide—Feeling abnormal—Capecitabine—kidney cancer	6.47e-05	0.000388	CcSEcCtD
Brinzolamide—Angiopathy—Doxorubicin—kidney cancer	6.47e-05	0.000388	CcSEcCtD
Brinzolamide—Immune system disorder—Doxorubicin—kidney cancer	6.44e-05	0.000386	CcSEcCtD
Brinzolamide—Mediastinal disorder—Doxorubicin—kidney cancer	6.42e-05	0.000385	CcSEcCtD
Brinzolamide—Arrhythmia—Doxorubicin—kidney cancer	6.37e-05	0.000382	CcSEcCtD
Brinzolamide—Dizziness—Paclitaxel—kidney cancer	6.33e-05	0.000379	CcSEcCtD
Brinzolamide—Alopecia—Doxorubicin—kidney cancer	6.3e-05	0.000377	CcSEcCtD
Brinzolamide—Mental disorder—Doxorubicin—kidney cancer	6.24e-05	0.000374	CcSEcCtD
Brinzolamide—Urticaria—Capecitabine—kidney cancer	6.24e-05	0.000374	CcSEcCtD
Brinzolamide—Erythema—Doxorubicin—kidney cancer	6.2e-05	0.000372	CcSEcCtD
Brinzolamide—Malnutrition—Doxorubicin—kidney cancer	6.2e-05	0.000372	CcSEcCtD
Brinzolamide—Flatulence—Doxorubicin—kidney cancer	6.11e-05	0.000366	CcSEcCtD
Brinzolamide—Tension—Doxorubicin—kidney cancer	6.09e-05	0.000365	CcSEcCtD
Brinzolamide—Vomiting—Paclitaxel—kidney cancer	6.09e-05	0.000365	CcSEcCtD
Brinzolamide—Dysgeusia—Doxorubicin—kidney cancer	6.08e-05	0.000364	CcSEcCtD
Brinzolamide—Rash—Paclitaxel—kidney cancer	6.04e-05	0.000362	CcSEcCtD
Brinzolamide—Dermatitis—Paclitaxel—kidney cancer	6.03e-05	0.000361	CcSEcCtD
Brinzolamide—Nervousness—Doxorubicin—kidney cancer	6.03e-05	0.000361	CcSEcCtD
Brinzolamide—Back pain—Doxorubicin—kidney cancer	6e-05	0.00036	CcSEcCtD
Brinzolamide—Headache—Paclitaxel—kidney cancer	6e-05	0.000359	CcSEcCtD
Brinzolamide—Muscle spasms—Doxorubicin—kidney cancer	5.96e-05	0.000358	CcSEcCtD
Brinzolamide—Vision blurred—Doxorubicin—kidney cancer	5.85e-05	0.00035	CcSEcCtD
Brinzolamide—Hypersensitivity—Capecitabine—kidney cancer	5.79e-05	0.000347	CcSEcCtD
Brinzolamide—Ill-defined disorder—Doxorubicin—kidney cancer	5.76e-05	0.000345	CcSEcCtD
Brinzolamide—Agitation—Doxorubicin—kidney cancer	5.7e-05	0.000342	CcSEcCtD
Brinzolamide—Nausea—Paclitaxel—kidney cancer	5.69e-05	0.000341	CcSEcCtD
Brinzolamide—Asthenia—Capecitabine—kidney cancer	5.64e-05	0.000338	CcSEcCtD
Brinzolamide—Malaise—Doxorubicin—kidney cancer	5.59e-05	0.000335	CcSEcCtD
Brinzolamide—Vertigo—Doxorubicin—kidney cancer	5.57e-05	0.000334	CcSEcCtD
Brinzolamide—Pruritus—Capecitabine—kidney cancer	5.56e-05	0.000333	CcSEcCtD
Brinzolamide—Palpitations—Doxorubicin—kidney cancer	5.48e-05	0.000329	CcSEcCtD
Brinzolamide—Cough—Doxorubicin—kidney cancer	5.41e-05	0.000325	CcSEcCtD
Brinzolamide—Diarrhoea—Capecitabine—kidney cancer	5.37e-05	0.000322	CcSEcCtD
Brinzolamide—Hypertension—Doxorubicin—kidney cancer	5.36e-05	0.000321	CcSEcCtD
Brinzolamide—CA1—Metabolism—ALDH1A1—kidney cancer	5.35e-05	0.000512	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—SLC5A3—kidney cancer	5.35e-05	0.000512	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PGK1—kidney cancer	5.35e-05	0.000512	CbGpPWpGaD
Brinzolamide—Arthralgia—Doxorubicin—kidney cancer	5.28e-05	0.000317	CcSEcCtD
Brinzolamide—Chest pain—Doxorubicin—kidney cancer	5.28e-05	0.000317	CcSEcCtD
Brinzolamide—Myalgia—Doxorubicin—kidney cancer	5.28e-05	0.000317	CcSEcCtD
Brinzolamide—CA2—Metabolism—LDHB—kidney cancer	5.25e-05	0.000502	CbGpPWpGaD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	5.25e-05	0.000314	CcSEcCtD
Brinzolamide—Discomfort—Doxorubicin—kidney cancer	5.22e-05	0.000313	CcSEcCtD
Brinzolamide—CA9—Metabolism—GPC3—kidney cancer	5.2e-05	0.000497	CbGpPWpGaD
Brinzolamide—Dizziness—Capecitabine—kidney cancer	5.19e-05	0.000311	CcSEcCtD
Brinzolamide—Dry mouth—Doxorubicin—kidney cancer	5.17e-05	0.00031	CcSEcCtD
Brinzolamide—CA1—Metabolism—PGK1—kidney cancer	5.13e-05	0.000491	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—SLC5A3—kidney cancer	5.13e-05	0.000491	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—ACHE—kidney cancer	5.09e-05	0.000487	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GSTT1—kidney cancer	5.09e-05	0.000487	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ITPR2—kidney cancer	5.08e-05	0.000485	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ITPR2—kidney cancer	5.08e-05	0.000485	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CA2—kidney cancer	5.06e-05	0.000484	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CRABP1—kidney cancer	5.06e-05	0.000484	CbGpPWpGaD
Brinzolamide—Infection—Doxorubicin—kidney cancer	5.03e-05	0.000302	CcSEcCtD
Brinzolamide—CA1—Metabolism—LDHB—kidney cancer	5.03e-05	0.000481	CbGpPWpGaD
Brinzolamide—Vomiting—Capecitabine—kidney cancer	4.99e-05	0.000299	CcSEcCtD
Brinzolamide—Nervous system disorder—Doxorubicin—kidney cancer	4.97e-05	0.000298	CcSEcCtD
Brinzolamide—CA5A—Metabolism—GSTT1—kidney cancer	4.96e-05	0.000474	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GSTT1—kidney cancer	4.96e-05	0.000474	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ACHE—kidney cancer	4.96e-05	0.000474	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ACHE—kidney cancer	4.96e-05	0.000474	CbGpPWpGaD
Brinzolamide—Rash—Capecitabine—kidney cancer	4.95e-05	0.000297	CcSEcCtD
Brinzolamide—Dermatitis—Capecitabine—kidney cancer	4.95e-05	0.000297	CcSEcCtD
Brinzolamide—Tachycardia—Doxorubicin—kidney cancer	4.94e-05	0.000296	CcSEcCtD
Brinzolamide—CA9—Metabolism—ALAD—kidney cancer	4.93e-05	0.000471	CbGpPWpGaD
Brinzolamide—Headache—Capecitabine—kidney cancer	4.92e-05	0.000295	CcSEcCtD
Brinzolamide—Skin disorder—Doxorubicin—kidney cancer	4.92e-05	0.000295	CcSEcCtD
Brinzolamide—CA14—Metabolism—SCARB1—kidney cancer	4.82e-05	0.000461	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ST3GAL2—kidney cancer	4.81e-05	0.00046	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	4.8e-05	0.000459	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTGS1—kidney cancer	4.77e-05	0.000456	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CA9—kidney cancer	4.74e-05	0.000454	CbGpPWpGaD
Brinzolamide—Hypotension—Doxorubicin—kidney cancer	4.73e-05	0.000284	CcSEcCtD
Brinzolamide—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	4.72e-05	0.000451	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ALDH1A1—kidney cancer	4.7e-05	0.00045	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ITPR2—kidney cancer	4.7e-05	0.00045	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—SCARB1—kidney cancer	4.69e-05	0.000449	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—SCARB1—kidney cancer	4.69e-05	0.000449	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PSMD7—kidney cancer	4.68e-05	0.000447	CbGpPWpGaD
Brinzolamide—Nausea—Capecitabine—kidney cancer	4.67e-05	0.00028	CcSEcCtD
Brinzolamide—CA5A—Metabolism—PTGS1—kidney cancer	4.65e-05	0.000444	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTGS1—kidney cancer	4.65e-05	0.000444	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	4.63e-05	0.000443	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GSTT1—kidney cancer	4.63e-05	0.000443	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ACHE—kidney cancer	4.63e-05	0.000443	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GSTT1—kidney cancer	4.63e-05	0.000443	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ACHE—kidney cancer	4.63e-05	0.000443	CbGpPWpGaD
Brinzolamide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	4.61e-05	0.000277	CcSEcCtD
Brinzolamide—Insomnia—Doxorubicin—kidney cancer	4.58e-05	0.000275	CcSEcCtD
Brinzolamide—CA5A—Metabolism—PSMD7—kidney cancer	4.56e-05	0.000436	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PSMD7—kidney cancer	4.56e-05	0.000436	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CA9—kidney cancer	4.55e-05	0.000435	CbGpPWpGaD
Brinzolamide—Paraesthesia—Doxorubicin—kidney cancer	4.55e-05	0.000273	CcSEcCtD
Brinzolamide—Dyspnoea—Doxorubicin—kidney cancer	4.51e-05	0.000271	CcSEcCtD
Brinzolamide—CA9—Metabolism—PGK1—kidney cancer	4.51e-05	0.000431	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—SLC5A3—kidney cancer	4.51e-05	0.000431	CbGpPWpGaD
Brinzolamide—Somnolence—Doxorubicin—kidney cancer	4.5e-05	0.00027	CcSEcCtD
Brinzolamide—Dyspepsia—Doxorubicin—kidney cancer	4.46e-05	0.000267	CcSEcCtD
Brinzolamide—CA14—Metabolism—BCHE—kidney cancer	4.43e-05	0.000424	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—LDHB—kidney cancer	4.42e-05	0.000423	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—CDKN2A—kidney cancer	4.41e-05	0.000421	CbGpPWpGaD
Brinzolamide—Decreased appetite—Doxorubicin—kidney cancer	4.4e-05	0.000264	CcSEcCtD
Brinzolamide—CA7—Metabolism—SCARB1—kidney cancer	4.38e-05	0.000419	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—SCARB1—kidney cancer	4.38e-05	0.000419	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—SLC5A5—kidney cancer	4.38e-05	0.000419	CbGpPWpGaD
Brinzolamide—Gastrointestinal disorder—Doxorubicin—kidney cancer	4.37e-05	0.000262	CcSEcCtD
Brinzolamide—Fatigue—Doxorubicin—kidney cancer	4.37e-05	0.000262	CcSEcCtD
Brinzolamide—CA1—Metabolism—CA9—kidney cancer	4.36e-05	0.000417	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTGS1—kidney cancer	4.34e-05	0.000415	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTGS1—kidney cancer	4.34e-05	0.000415	CbGpPWpGaD
Brinzolamide—Pain—Doxorubicin—kidney cancer	4.33e-05	0.00026	CcSEcCtD
Brinzolamide—CA5A—Metabolism—BCHE—kidney cancer	4.32e-05	0.000413	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—BCHE—kidney cancer	4.32e-05	0.000413	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GSTT1—kidney cancer	4.29e-05	0.00041	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ACHE—kidney cancer	4.29e-05	0.00041	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—SLC5A5—kidney cancer	4.27e-05	0.000408	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—SLC5A5—kidney cancer	4.27e-05	0.000408	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PSMD7—kidney cancer	4.25e-05	0.000407	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PSMD7—kidney cancer	4.25e-05	0.000407	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—RELA—kidney cancer	4.24e-05	0.000405	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—SLC2A1—kidney cancer	4.23e-05	0.000404	CbGpPWpGaD
Brinzolamide—Feeling abnormal—Doxorubicin—kidney cancer	4.17e-05	0.00025	CcSEcCtD
Brinzolamide—CA9—Cellular responses to stress—MTOR—kidney cancer	4.16e-05	0.000398	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—SLC2A1—kidney cancer	4.12e-05	0.000394	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—SLC2A1—kidney cancer	4.12e-05	0.000394	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—SCARB1—kidney cancer	4.06e-05	0.000388	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CRABP1—kidney cancer	4.03e-05	0.000386	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—BCHE—kidney cancer	4.03e-05	0.000386	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—BCHE—kidney cancer	4.03e-05	0.000386	CbGpPWpGaD
Brinzolamide—Urticaria—Doxorubicin—kidney cancer	4.02e-05	0.000241	CcSEcCtD
Brinzolamide—CA12—Metabolism—PTGS1—kidney cancer	4.02e-05	0.000384	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—SLC5A5—kidney cancer	3.98e-05	0.000381	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—SLC5A5—kidney cancer	3.98e-05	0.000381	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PSMD7—kidney cancer	3.94e-05	0.000377	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—CDKN1B—kidney cancer	3.9e-05	0.000373	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CRABP1—kidney cancer	3.87e-05	0.00037	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—SLC2A1—kidney cancer	3.85e-05	0.000368	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—SLC2A1—kidney cancer	3.85e-05	0.000368	CbGpPWpGaD
Brinzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	3.82e-05	0.000365	CbGpPWpGaD
Brinzolamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	3.76e-05	0.00036	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ITPR2—kidney cancer	3.75e-05	0.000359	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—BCHE—kidney cancer	3.74e-05	0.000357	CbGpPWpGaD
Brinzolamide—Hypersensitivity—Doxorubicin—kidney cancer	3.73e-05	0.000224	CcSEcCtD
Brinzolamide—CA9—Cellular responses to stress—JUN—kidney cancer	3.71e-05	0.000355	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CRABP1—kidney cancer	3.71e-05	0.000355	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—SLC5A5—kidney cancer	3.69e-05	0.000353	CbGpPWpGaD
Brinzolamide—Asthenia—Doxorubicin—kidney cancer	3.63e-05	0.000218	CcSEcCtD
Brinzolamide—CA2—Metabolism—ITPR2—kidney cancer	3.6e-05	0.000344	CbGpPWpGaD
Brinzolamide—Pruritus—Doxorubicin—kidney cancer	3.58e-05	0.000215	CcSEcCtD
Brinzolamide—CA12—Metabolism—SLC2A1—kidney cancer	3.56e-05	0.000341	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GSTP1—kidney cancer	3.53e-05	0.000337	CbGpPWpGaD
Brinzolamide—Diarrhoea—Doxorubicin—kidney cancer	3.46e-05	0.000208	CcSEcCtD
Brinzolamide—CA1—Metabolism—ITPR2—kidney cancer	3.45e-05	0.00033	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GSTP1—kidney cancer	3.44e-05	0.000329	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GSTP1—kidney cancer	3.44e-05	0.000329	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTT1—kidney cancer	3.42e-05	0.000327	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ACHE—kidney cancer	3.42e-05	0.000327	CbGpPWpGaD
Brinzolamide—Dizziness—Doxorubicin—kidney cancer	3.35e-05	0.000201	CcSEcCtD
Brinzolamide—CA14—Metabolism—ABCB1—kidney cancer	3.34e-05	0.000319	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTT1—kidney cancer	3.28e-05	0.000314	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ACHE—kidney cancer	3.28e-05	0.000314	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CRABP1—kidney cancer	3.26e-05	0.000312	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ABCB1—kidney cancer	3.25e-05	0.000311	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ABCB1—kidney cancer	3.25e-05	0.000311	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—VEGFA—kidney cancer	3.24e-05	0.00031	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GSTM1—kidney cancer	3.24e-05	0.00031	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—SCARB1—kidney cancer	3.24e-05	0.00031	CbGpPWpGaD
Brinzolamide—Vomiting—Doxorubicin—kidney cancer	3.22e-05	0.000193	CcSEcCtD
Brinzolamide—CA7—Metabolism—GSTP1—kidney cancer	3.21e-05	0.000307	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GSTP1—kidney cancer	3.21e-05	0.000307	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTGS1—kidney cancer	3.21e-05	0.000306	CbGpPWpGaD
Brinzolamide—Rash—Doxorubicin—kidney cancer	3.19e-05	0.000191	CcSEcCtD
Brinzolamide—Dermatitis—Doxorubicin—kidney cancer	3.19e-05	0.000191	CcSEcCtD
Brinzolamide—Headache—Doxorubicin—kidney cancer	3.17e-05	0.00019	CcSEcCtD
Brinzolamide—CA5A—Metabolism—GSTM1—kidney cancer	3.16e-05	0.000302	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GSTM1—kidney cancer	3.16e-05	0.000302	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTT1—kidney cancer	3.14e-05	0.000301	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ACHE—kidney cancer	3.14e-05	0.000301	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PSMD7—kidney cancer	3.14e-05	0.000301	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—SCARB1—kidney cancer	3.1e-05	0.000297	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	3.09e-05	0.000296	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CYP1A1—kidney cancer	3.07e-05	0.000294	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTGS1—kidney cancer	3.07e-05	0.000294	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—MAPK3—kidney cancer	3.07e-05	0.000294	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ABCB1—kidney cancer	3.04e-05	0.00029	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ABCB1—kidney cancer	3.04e-05	0.00029	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ITPR2—kidney cancer	3.03e-05	0.00029	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PSMD7—kidney cancer	3.01e-05	0.000288	CbGpPWpGaD
Brinzolamide—Nausea—Doxorubicin—kidney cancer	3.01e-05	0.00018	CcSEcCtD
Brinzolamide—CA5A—Metabolism—CYP1A1—kidney cancer	2.99e-05	0.000286	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CYP1A1—kidney cancer	2.99e-05	0.000286	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—BCHE—kidney cancer	2.98e-05	0.000285	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—SCARB1—kidney cancer	2.98e-05	0.000285	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GSTP1—kidney cancer	2.97e-05	0.000284	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GSTM1—kidney cancer	2.95e-05	0.000282	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GSTM1—kidney cancer	2.95e-05	0.000282	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTGS1—kidney cancer	2.95e-05	0.000282	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—SLC5A5—kidney cancer	2.94e-05	0.000281	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—MAPK1—kidney cancer	2.92e-05	0.000279	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PSMD7—kidney cancer	2.89e-05	0.000276	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—BCHE—kidney cancer	2.86e-05	0.000273	CbGpPWpGaD
Brinzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.84e-05	0.000272	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—SLC2A1—kidney cancer	2.84e-05	0.000272	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—SLC5A5—kidney cancer	2.82e-05	0.00027	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ABCB1—kidney cancer	2.81e-05	0.000269	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CYP1A1—kidney cancer	2.8e-05	0.000267	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CYP1A1—kidney cancer	2.8e-05	0.000267	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ACHE—kidney cancer	2.76e-05	0.000264	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTT1—kidney cancer	2.76e-05	0.000264	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—BCHE—kidney cancer	2.74e-05	0.000262	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GSTM1—kidney cancer	2.73e-05	0.000261	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—SLC2A1—kidney cancer	2.73e-05	0.000261	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTT1—kidney cancer	2.72e-05	0.00026	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—SLC5A5—kidney cancer	2.71e-05	0.000259	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—SCARB1—kidney cancer	2.62e-05	0.00025	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—SLC2A1—kidney cancer	2.61e-05	0.00025	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTGS1—kidney cancer	2.59e-05	0.000248	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP1A1—kidney cancer	2.59e-05	0.000248	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—PTGS1—kidney cancer	2.55e-05	0.000244	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PSMD7—kidney cancer	2.54e-05	0.000243	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—TP53—kidney cancer	2.45e-05	0.000234	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—BCHE—kidney cancer	2.41e-05	0.00023	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—SLC5A5—kidney cancer	2.38e-05	0.000227	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTP1—kidney cancer	2.37e-05	0.000227	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.31e-05	0.000221	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—SLC2A1—kidney cancer	2.3e-05	0.00022	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—POMC—kidney cancer	2.29e-05	0.000219	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTP1—kidney cancer	2.27e-05	0.000217	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ABCB1—kidney cancer	2.24e-05	0.000215	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—POMC—kidney cancer	2.23e-05	0.000214	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—POMC—kidney cancer	2.23e-05	0.000214	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTP1—kidney cancer	2.18e-05	0.000208	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTM1—kidney cancer	2.18e-05	0.000208	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ABCB1—kidney cancer	2.15e-05	0.000206	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTM1—kidney cancer	2.09e-05	0.0002	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—POMC—kidney cancer	2.08e-05	0.000199	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—POMC—kidney cancer	2.08e-05	0.000199	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP1A1—kidney cancer	2.07e-05	0.000198	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ABCB1—kidney cancer	2.06e-05	0.000197	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTM1—kidney cancer	2e-05	0.000191	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP1A1—kidney cancer	1.98e-05	0.000189	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—POMC—kidney cancer	1.93e-05	0.000185	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTP1—kidney cancer	1.92e-05	0.000183	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP1A1—kidney cancer	1.9e-05	0.000182	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.89e-05	0.00018	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.86e-05	0.000178	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTGS2—kidney cancer	1.83e-05	0.000175	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ABCB1—kidney cancer	1.81e-05	0.000173	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTGS2—kidney cancer	1.78e-05	0.00017	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTGS2—kidney cancer	1.78e-05	0.00017	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTM1—kidney cancer	1.76e-05	0.000168	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.73e-05	0.000166	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.71e-05	0.000163	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP1A1—kidney cancer	1.67e-05	0.00016	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTGS2—kidney cancer	1.66e-05	0.000159	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTGS2—kidney cancer	1.66e-05	0.000159	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.64e-05	0.000157	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.62e-05	0.000155	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTEN—kidney cancer	1.59e-05	0.000152	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTEN—kidney cancer	1.55e-05	0.000149	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTEN—kidney cancer	1.55e-05	0.000149	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTGS2—kidney cancer	1.54e-05	0.000147	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—POMC—kidney cancer	1.54e-05	0.000147	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—POMC—kidney cancer	1.48e-05	0.000141	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTEN—kidney cancer	1.45e-05	0.000139	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTEN—kidney cancer	1.45e-05	0.000139	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ACY1—kidney cancer	1.45e-05	0.000138	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—POMC—kidney cancer	1.42e-05	0.000135	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTEN—kidney cancer	1.34e-05	0.000128	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—POMC—kidney cancer	1.24e-05	0.000119	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PDHB—kidney cancer	1.23e-05	0.000118	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTGS2—kidney cancer	1.23e-05	0.000117	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—POMC—kidney cancer	1.22e-05	0.000117	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTGS2—kidney cancer	1.18e-05	0.000113	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CCBL1—kidney cancer	1.16e-05	0.00011	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTGS2—kidney cancer	1.13e-05	0.000108	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CA—kidney cancer	1.12e-05	0.000108	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CA—kidney cancer	1.1e-05	0.000105	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CA—kidney cancer	1.1e-05	0.000105	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTEN—kidney cancer	1.07e-05	0.000102	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTEN—kidney cancer	1.03e-05	9.82e-05	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CA—kidney cancer	1.02e-05	9.78e-05	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CA—kidney cancer	1.02e-05	9.78e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GLIPR1—kidney cancer	1e-05	9.58e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PPAT—kidney cancer	1e-05	9.58e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTGS2—kidney cancer	9.92e-06	9.49e-05	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTEN—kidney cancer	9.85e-06	9.42e-05	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CA—kidney cancer	9.48e-06	9.06e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—APRT—kidney cancer	9.31e-06	8.9e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—FH—kidney cancer	9.31e-06	8.9e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GPC3—kidney cancer	8.76e-06	8.37e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTEN—kidney cancer	8.66e-06	8.28e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CA2—kidney cancer	8.52e-06	8.14e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALAD—kidney cancer	8.3e-06	7.94e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ST3GAL2—kidney cancer	8.1e-06	7.75e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALDH1A1—kidney cancer	7.92e-06	7.57e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PGK1—kidney cancer	7.59e-06	7.26e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC5A3—kidney cancer	7.59e-06	7.26e-05	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CA—kidney cancer	7.56e-06	7.23e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—LDHB—kidney cancer	7.44e-06	7.12e-05	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CA—kidney cancer	7.24e-06	6.93e-05	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CA—kidney cancer	6.95e-06	6.64e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CA9—kidney cancer	6.45e-06	6.17e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CA—kidney cancer	6.11e-06	5.84e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CRABP1—kidney cancer	5.49e-06	5.25e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ITPR2—kidney cancer	5.1e-06	4.88e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ACHE—kidney cancer	4.65e-06	4.45e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTT1—kidney cancer	4.65e-06	4.45e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SCARB1—kidney cancer	4.4e-06	4.21e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTGS1—kidney cancer	4.36e-06	4.17e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PSMD7—kidney cancer	4.28e-06	4.09e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—BCHE—kidney cancer	4.05e-06	3.88e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC5A5—kidney cancer	4e-06	3.83e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.87e-06	3.7e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTP1—kidney cancer	3.23e-06	3.08e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ABCB1—kidney cancer	3.05e-06	2.92e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTM1—kidney cancer	2.96e-06	2.83e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.81e-06	2.69e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—POMC—kidney cancer	2.09e-06	2e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTGS2—kidney cancer	1.67e-06	1.6e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTEN—kidney cancer	1.46e-06	1.39e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.03e-06	9.83e-06	CbGpPWpGaD
